Innoviva Specialty Therapeutics
Innoviva Specialty Therapeutics
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Recruiting | Phase 1 | 2026-10-06 | NCT06801223 | |
| A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) | Recruiting | Not stated | 2026-06-24 | NCT06746883 | |
| Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, Urogenital Diseases, acute kidney injury, cirrhosis of liver, kidney disorder, kidney failure, toxic shock syndrome, urinary system disorder | Active, not recruiting | Early phase 1 | 2026-05-05 | NCT07568275 | |
| A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI) | Complicated Intra-abdominal Infections (cIAI) | Recruiting | Phase 2 | 2026-05-05 | NCT06794541 | |
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus Infection, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Not yet recruiting | Phase 2 | 2026-03-20 | NCT07485010 | |
| Synthetic Angiotensin II/Giapreza in Pediatric Patients With Refractory Hypotension | Vasodilatory Shock | Enrolling by invitation | Phase 4 | 2025-10-08 | NCT07212686 |